Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

BACKGROUND: This international study aimed to characterise the impact of acute SARS-CoV-2 infection in people with cystic fibrosis and investigate factors associated with severe outcomes. Methods Data from 22 countries prior to 13(th) December 2020 and the introduction of vaccines were included. It...

Descripción completa

Detalles Bibliográficos
Autores principales: Carr, Siobhán B, McClenaghan, Elliot, Elbert, Alexander, Faro, Albert, Cosgriff, Rebecca, Abdrakhmanov, Olzhas, Brownlee, Keith, Burgel, Pierre-Régis, Byrnes, Catherine A, Cheng, Stephanie Y, Colombo, Carla, Corvol, Harriet, Daneau, Géraldine, Goss, Christopher H, Gulmans, Vincent, Gutierrez, Hector, Harutyunyan, Satenik, Helmick, Meagan, Jung, Andreas, Kashirskaya, Nataliya, McKone, Edward, Melo, Joel, Middleton, Peter G, Mondejar-Lopez, Pedro, de Monestrol, Isabelle, Nährlich, Lutz, Padoan, Rita, Parker, Megan, Pastor-Vivero, M Dolores, Rizvi, Samar, Ruseckaite, Rasa, Salvatore, Marco, da Silva-Filho, Luiz Vicente R F, Versmessen, Nick, Zampoli, Marco, Marshall, Bruce C, Stephenson, Anne L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. Published by Elsevier B.V. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189103/
https://www.ncbi.nlm.nih.gov/pubmed/35753987
http://dx.doi.org/10.1016/j.jcf.2022.06.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189103/
https://www.ncbi.nlm.nih.gov/pubmed/35753987
http://dx.doi.org/10.1016/j.jcf.2022.06.006

Ejemplares similares